Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 568971

74 MBq I–131 does significantly reduce subsequent ablation absorbed dose


Medvedec, Mario; Pavlinović, Željka; Dodig, Damir
74 MBq I–131 does significantly reduce subsequent ablation absorbed dose // 46th Annual Meeting of The Society of Nuclear Medicine : abstracts, The Journal of nuclear medicine 40(5) suppl. 1 / Sandler, Martin (ur.).
Reston (VA): The Society of Nuclear Medicine, 1999. str. 132P-132P (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 568971 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
74 MBq I–131 does significantly reduce subsequent ablation absorbed dose

Autori
Medvedec, Mario ; Pavlinović, Željka ; Dodig, Damir

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
46th Annual Meeting of The Society of Nuclear Medicine : abstracts, The Journal of nuclear medicine 40(5) suppl. 1 / Sandler, Martin - Reston (VA) : The Society of Nuclear Medicine, 1999, 132P-132P

Skup
46th Annual Meeting of The Society of Nuclear Medicine 1999

Mjesto i datum
Los Angeles (CA), Sjedinjene Američke Države, 06.06.1999. - 10.06.1999

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
thyroid cancer ; radioiodine-131 ; activity ; thyroid stunning

Sažetak
74 MBq I–131 does significantly reduce subsequent ablation absorbed dose.

Izvorni jezik
Engleski

Znanstvena područja
Fizika, Elektrotehnika, Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Damir Dodig (autor)

Avatar Url Željka Pavlinović (autor)

Avatar Url Mario Medvedec (autor)


Citiraj ovu publikaciju:

Medvedec, Mario; Pavlinović, Željka; Dodig, Damir
74 MBq I–131 does significantly reduce subsequent ablation absorbed dose // 46th Annual Meeting of The Society of Nuclear Medicine : abstracts, The Journal of nuclear medicine 40(5) suppl. 1 / Sandler, Martin (ur.).
Reston (VA): The Society of Nuclear Medicine, 1999. str. 132P-132P (poster, međunarodna recenzija, sažetak, znanstveni)
Medvedec, M., Pavlinović, Ž. & Dodig, D. (1999) 74 MBq I–131 does significantly reduce subsequent ablation absorbed dose. U: Sandler, M. (ur.)46th Annual Meeting of The Society of Nuclear Medicine : abstracts, The Journal of nuclear medicine 40(5) suppl. 1.
@article{article, author = {Medvedec, Mario and Pavlinovi\'{c}, \v{Z}eljka and Dodig, Damir}, editor = {Sandler, M.}, year = {1999}, pages = {132P-132P}, keywords = {thyroid cancer, radioiodine-131, activity, thyroid stunning}, title = {74 MBq I–131 does significantly reduce subsequent ablation absorbed dose}, keyword = {thyroid cancer, radioiodine-131, activity, thyroid stunning}, publisher = {The Society of Nuclear Medicine}, publisherplace = {Los Angeles (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave} }
@article{article, author = {Medvedec, Mario and Pavlinovi\'{c}, \v{Z}eljka and Dodig, Damir}, editor = {Sandler, M.}, year = {1999}, pages = {132P-132P}, keywords = {thyroid cancer, radioiodine-131, activity, thyroid stunning}, title = {74 MBq I–131 does significantly reduce subsequent ablation absorbed dose}, keyword = {thyroid cancer, radioiodine-131, activity, thyroid stunning}, publisher = {The Society of Nuclear Medicine}, publisherplace = {Los Angeles (CA), Sjedinjene Ameri\v{c}ke Dr\v{z}ave} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font